Clinical trial
IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
NCT01392482 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- September 30, 2012
- Enrollment
- 751,725 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.